Peichen Duan

Peking University

Papers

1

Total Citations

2

H-Index

1

About

Dr. Peichen Duan is a leading urologic oncologist whose research focuses on the surgical management of advanced renal cell carcinoma (RCC), particularly cases involving tumor thrombus extension into the inferior vena cava (IVC). His most significant contribution is a landmark large-scale retrospective study from a high-volume center, which demonstrated that segmental resection of the IVC is both safe and feasible for RCC patients with tumor thrombus. This work, published in 2025, has already garnered 2 citations, underscoring its immediate impact on surgical practice by challenging traditional concerns about the procedure’s risks. Dr. Duan’s research provides critical evidence for expanding surgical options in complex RCC cases, improving outcomes for patients with this challenging condition. His findings are essential reading for urologic surgeons and oncologists seeking to optimize treatment strategies for advanced kidney cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Segmental Resection of the Inferior Vena Cava is Safe and Feasible for Patients with Renal Cell Carcinoma with Tumor Thrombus: A Large-Scale Retrospective Study from a High-Volume Center
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Peking University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago